コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 22.0% during chemoradiotherapy, 13.4% during maintenance chemotherapy).
2 motherapy (fluorouracil and cisplatin) or no maintenance chemotherapy.
3 s SCT or intensive consolidation followed by maintenance chemotherapy.
4 cranial radiation only (18 Gy), followed by maintenance chemotherapy.
5 survival and overall survival compared with maintenance chemotherapy.
6 rfractionated craniospinal radiotherapy, and maintenance chemotherapy.
7 then administered, followed by 1.5 years of maintenance chemotherapy.
8 apy and was continued for up to 12 cycles of maintenance chemotherapy.
9 ll-Cell Lung Cancer (NSCLC) regarding switch maintenance chemotherapy.
11 hemoradiation improves response, and whether maintenance chemotherapy after chemoradiation improves s
14 y fractions); with or without two courses of maintenance chemotherapy (fluorouracil and cisplatin at
15 econd randomisation after initial therapy to maintenance chemotherapy (fluorouracil and cisplatin) or
16 value of alloSCT compared with conventional maintenance chemotherapy for patients in first complete
18 e baseline CA-125 level before initiation of maintenance chemotherapy in women achieving a clinically
20 Patients on regimen A received 6 months of maintenance chemotherapy (MC) with cyclophosphamide and
21 ved ch14.18, 99 received a 12-month low-dose maintenance chemotherapy (MT) instead, and 69 had no add
22 a (ALL) of the duration and the intensity of maintenance chemotherapy need to be assessed reliably.
23 r autografting, and the development of novel maintenance chemotherapy or immunotherapy strategies is
24 e baseline CA-125 level before initiation of maintenance chemotherapy strongly predicts the risk of s
26 stem-cell transplantation (n=149) or to oral maintenance chemotherapy with cyclophosphamide (n=146).
29 tumors can avoid radiotherapy and prolonged maintenance chemotherapy yet still achieve durable remis
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。